Top Markets
Coin of the day
PharmaSGP Holding SE PharmaSGP Holding SE

PharmaSGP Holding SE

PSG
Rang in Aktien #14725
Founded in 2012 and based in Gräfelfing, Germany, PharmaSGP Holding SE... Founded in 2012 and based in Gräfelfing, Germany, PharmaSGP Holding SE specializes in the production of over-the-counter (OTC) pharmaceuticals and diverse healthcare goods. The company offers an extensive portfolio of products addressing various health concerns. This includes Baldriparan for sleep disturbances; pain relief solutions like Spalt, Formigran, and Kamol massage cream; RubaXX, specifically designed for rheumatic pain in bones, tendons, and muscles; and Restaxil, which targets nerve pain in the neck and back. Furthermore, their offerings encompass Fulminan, a beauty beverage for areas such as the eyes, buttocks, and thighs; DESEO drops for sexual weakness; Neradin, a medication for sexual dysfunction; and TAUMEA, aimed at managing vertigo. PharmaSGP also develops treatments for chronic conditions, including persistent pain and other age-associated ailments. Its products reach consumers via pharmacies and wholesalers, and are exported to several European nations, including Austria, Italy, Belgium, Spain, and France.
Aktienkurs
$34.40
Zuletzt synchronisiert: 2025-08-11
Marktkapitalisierung
$396.01M
Veränderung (1 Tag)
1.83%
Veränderung (1 Jahr)
0.00%
Land
DE
Handel PharmaSGP Holding SE (PSG)

Kategorie

Kursverlauf für PharmaSGP Holding SE (PSG)
Höchster Schlusskurs: $33.74 am 2025-08-01

Niedrigster Schlusskurs: $6.24 am 2011-02-01
Kursverlauf der Aktie von PharmaSGP Holding SE von 2011 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2025 32.25%
2024 15.81%
2023 -19.38%
2022 -0.56%
2021 -2.10%
2020 349.83%
2011 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$171.67 -
DE
$167.72 31.75%
DE
$38.30 26.13%
JP
$21.25 19.61%
IN
$214.79 22.87%
CH